DocuSign, Inc. DOCU | NASDAQ

$82.12 $1.27 | 1.56%

Next Earnings: Jun 04, 2025

Company Overview:

Market Cap: $16.63B
PE Ratio: 16.16
52-Week Range: $48.70 - $107.86

6.3 Year Performance Metrics:

Total Return (with DRIP): 63.50% (8.12% / yr)
Total Return (no DRIP): 63.50% (8.12% / yr)
Share Price: 63.50%
DOCU Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

DOCU Earnings, Revenue, Cash & Debt, Shares Outstaning:

DOCU - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
DOCU - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
DOCU - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
DOCU - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
DOCU - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
DOCU - Cash & Debt
14-Day FREE Trial Get Full Access Now!
DOCU - Revenue
14-Day FREE Trial Get Full Access Now!
DOCU Revenue CAGR:1Y: 7.77%2Y: 8.14%5Y: 24.78%10Y: 0.00%
DOCU - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
DOCU EPS CAGR:1Y: 57.89%2Y: 100.00%5Y: 25.83%10Y: 0.00%
DOCU - Net Income
14-Day FREE Trial Get Full Access Now!
DOCU Net Income CAGR:1Y: 60.86%2Y: 102.24%5Y: 27.27%10Y: 0.00%
DOCU - EBITDA
14-Day FREE Trial Get Full Access Now!
DOCU EBITDA CAGR:1Y: 64.00%2Y: 108.09%5Y: 42.62%10Y: 0.00%
DOCU - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
DOCU Free Cash Flow CAGR:1Y: -12.33%2Y: 141.73%5Y: 76.01%10Y: 0.00%
DOCU - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
DOCU Free Cash Flow / Share CAGR:1Y: -11.94%2Y: 140.44%5Y: 71.98%10Y: 0.00%
DOCU - Gross Profit
14-Day FREE Trial Get Full Access Now!
DOCU Gross Profit CAGR:1Y: 7.26%2Y: 7.69%5Y: 26.11%10Y: 0.00%
DOCU - Expenses
14-Day FREE Trial Get Full Access Now!
DOCU Expenses CAGR:1Y: -0.96%2Y: 19.71%5Y: 13.97%10Y: 0.00%
DOCU - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
DOCU Shares Outstanding CAGR:1Y: 0.31%2Y: 1.80%5Y: 3.20%10Y: 0.00%
DOCU - Share Buybacks
14-Day FREE Trial Get Full Access Now!
DOCU Share Buybacks CAGR:1Y: 130.11%2Y: 113.07%5Y: 0.00%10Y: 0.00%
DOCU - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
DOCU Stock-Based Comp CAGR:1Y: -3.88%2Y: 4.31%5Y: 23.78%10Y: 0.00%
DOCU - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
DOCU Revenue CAGR:1Y: 7.77%2Y: 8.14%5Y: 24.78%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

DOCU - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
DOCU Actual Revenue CAGR:1Y: 7.77%2Y: 8.14%5Y: 24.78%10Y: 0.00%
DOCU - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
DOCU Actual EPS CAGR:1Y: 57.89%2Y: 100.00%5Y: 25.83%10Y: 0.00%
DOCU - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
DOCU Actual Net Income CAGR:1Y: 60.86%2Y: 102.24%5Y: 27.27%10Y: 0.00%
DOCU - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
DOCU Actual EBITDA CAGR:1Y: 64.00%2Y: 108.09%5Y: 42.62%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

DOCU - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
DOCU Net Profit Margin CAGR:1Y: 49.28%2Y: 94.58%5Y: 19.56%10Y: 0.00%
DOCU - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
DOCU Gross Profit Margin CAGR:1Y: -0.46%2Y: -0.42%5Y: 1.07%10Y: 0.00%
DOCU - Price to Earnings
14-Day FREE Trial Get Full Access Now!
DOCU - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
DOCU - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
DOCU - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for DOCU

Based on past 6.3-year performance, here are DOCU growth metrics:

Share price CAGR of +8.12%
Dividend CAGR of +0%

Using DOCU CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

DOCU (DRIP)DOCU - No DRIP
Current Price$80.85$80.85
Start Shares123.69123.69
Start Value$10,000$10,000
  
After 10 years:
Final Share Count123.69123.69
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$163.19$80.85
Total Dividends$0$0
Final Value$20,185$10,000

Estimated Future Value + Dividends - DOCU

NOTE: Above numbers are our estimate based on DOCU's Dividend and Price CAGR over past 6.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

DocuSign, Inc. (DOCU) had its IPO on 2018-04-27, and is trader on NASDAQ stock exchange.

DocuSign, Inc. provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management. The company provides Guided Forms, which enable complex forms to be filled via an interactive and step-by-step process; Click that supports no-signature-required agreements for standard terms and consents; Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Payments that enables customers to collect signatures and payment; Remote Online Notary is a solution using audio-visual and identify verification technologies to enable notarization; and Monitor using advanced analytics to track DocuSign eSignature web, mobile, and API account. It offers industry-specific cloud offerings, including Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; Rooms for Mortgage, which offers digital workspace to create and close mortgages; FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise, commercial, and small businesses. The company was incorporated in 2003 and is headquartered in San Francisco, California.

DOCU website: https://www.DocuSign.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial